Articles that tag BEAT but are mainly about other companies.
Strategic collaboration with Mount Sinai to develop next-generation AI-ECG algorithms, combined with recent FDA clearances (arrhythmia assessment and 12-lead ECG synthesis), positions company for expanded clinical applications and market reach.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
